McCormack VA, dos Santos SI (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169. https://doi.org/10.1158/1055-9965.EPI-06-0034

Article  PubMed  Google Scholar 

Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–9

Article  CAS  PubMed  Google Scholar 

Gram IT, Bremnes Y, Ursin G, Maskarinec G, Bjurstam N, Lund E (2005) Percentage density, Wolfe’s and Tabár’s mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Res 7:R854–R861. https://doi.org/10.1186/bcr1308

Article  PubMed  PubMed Central  Google Scholar 

Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087. https://doi.org/10.1093/jnci/92.13.1081

Article  CAS  PubMed  Google Scholar 

Wanders JO, Holland K, Veldhuis WB, Mann RM, Pijnappel RM, Peeters PH, van Gils CH, Karssemeijer N (2017) Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res Treat 162:95–103. https://doi.org/10.1007/s10549-016-4090-7

Article  PubMed  Google Scholar 

Bakker MF, de Lange SV, Pijnappel RM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381:2091–2102. https://doi.org/10.1056/NEJMoa1903986

Article  PubMed  Google Scholar 

Loibl S, André F, Bachelot T et al (2023) Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up†. Ann Oncol S0923–7534(23):05104–9

Google Scholar 

Korde LA, Somerfield MR, Carey LA et al (2021) Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO Guideline. J Clin Oncol 39:1485–1505. https://doi.org/10.1200/JCO.20.03399

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bartsch R, Bergen E, Galid A (2018) Current concepts and future directions in neoadjuvant chemotherapy of breast cancer. Memo 11:199–203. https://doi.org/10.1007/s12254-018-0421-1

Article  PubMed  PubMed Central  Google Scholar 

Mougalian SS, Soulos PR, Killelea BK et al (2015) Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer 121:2544–2552. https://doi.org/10.1002/cncr.29348

Article  PubMed  Google Scholar 

Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18. J Clin Oncol 15:2483–2493. https://doi.org/10.1200/JCO.1997.15.7.2483

Article  CAS  PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19:27–39. https://doi.org/10.1016/S1470-2045(17)30777-5

Article  Google Scholar 

Cain H, Macpherson IR, Beresford M, Pinder SE, Pong J, Dixon JM (2017) Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clin Oncol (R Coll Radiol) 29:642–652. https://doi.org/10.1016/j.clon.2017.06.003

Article  CAS  PubMed  Google Scholar 

Loibl S, von Minckwitz G, Untch M, Denkert C, German Breast Group (2014) Predictive factors for response to neoadjuvant therapy in breast cancer. Oncol Res Treat 37:563–8. https://doi.org/10.1159/000367643

Article  CAS  PubMed  Google Scholar 

Elsamany S, Alzahrani A, Abozeed WN, Rasmy A, Farooq MU, Elbiomy MA, Rawah E, Alsaleh K, Abdel-Aziz NM (2015) Mammographic breast density: predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast 24:576–581. https://doi.org/10.1016/j.breast.2015.05.007

Article  CAS  PubMed  Google Scholar 

Skarping I, Förnvik D, Sartor H, Heide-Jørgensen U, Zackrisson S, Borgquist S (2019) Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer. BMC Cancer 19:1272. https://doi.org/10.1186/s12885-019-6485-4

Article  PubMed  PubMed Central  Google Scholar 

Skarping I, Förnvik D, Heide-Jørgensen U, Sartor H, Hall P, Zackrisson S, Borgquist S (2021) Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients. Cancer Causes Control 32:251–260. https://doi.org/10.1007/s10552-020-01379-w

Article  PubMed  Google Scholar 

Zdanowski A, Sartor H, Feldt M, Skarping I (2023) Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy. Front Oncol 13:1177310. https://doi.org/10.3389/fonc.2023.1177310

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rojas KI, Flores R, Flores CJ, Pinto JA, Gomez HL, Castañeda C et al (2014) Mamographic density and disease-free survival in [HR+, HER2-] locally advanced breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 32:e11536. https://doi.org/10.1200/jco.2014.32.15_suppl.e11536

Article  Google Scholar 

Rella R, Bufi E, Belli P et al (2020) Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy. Diagn Interv Imaging 101:649–655. https://doi.org/10.1016/j.diii.2020.05.010

Rella R, Bufi E, Belli P et al (2022) Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy. Diagn Interv Imaging 103:486-494. https://doi.org/10.1016/j.diii.2022.04.004.

Sickles EA, D’Orsi CJ, Bassett LW et al (2013) ACR BI-RADS Mammography. In: D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (eds) ACR BI-RADS Atlas, Breast Imaging Reporting and Data System, 5th edn. American College of Radiology, Reston, VA, USA

Google Scholar 

Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377. https://doi.org/10.1038/bjc.1957.43

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolff AC, Hammond ME, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline update. J Clin Oncol 31:3997–4013. https://doi.org/10.1200/JCO.2013.50.9984

Article  PubMed  Google Scholar 

Giuliano AE, Edge SB, Hortobagyi GN (2018) Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol 25:1783–1785. https://doi.org/10.1245/s10434-018-6486-6

Article  PubMed  Google Scholar 

Skarping I, Förnvik D, Heide-Jørgensen U, Sartor H, Hall P, Zackrisson S, Borgquist S (2020) Mammographic density changes during neoadjuvant breast cancer treatment: neodense, a prospective study in Sweden. Breast 53:33–41. https://doi.org/10.1016/j.breast.2020.05.013

Article  PubMed  PubMed Central  Google Scholar 

Ding J, Warren R, Girling A, Thompson D, Easton D (2010) Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 16:279–289. https://doi.org/10.1111/j.1524-4741.2010.00907.x

Article  PubMed  Google Scholar 

Conroy SM, Pagano I, Kolonel LN, Maskarinec G (2011) Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol 35:448–452. https://doi.org/10.1016/j.canep.2010.11.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin LJ, Boyd NF (2008) Mammographic density Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. https://doi.org/10.1186/bcr1831

Article  PubMed  PubMed Central  Google Scholar 

Gierach GL, Ichikawa L, Kerlikowske K et al (2012) Relationship between mammographic density and breast cancer death in the Breast cancer surveillance consortium. J Natl Cancer Inst 104:1218–1227. https://doi.org/10.1093/jnci/djs327

Article  PubMed  PubMed Central  Google Scholar 

Castaneda CA, Flores R, Rojas K, Flores C, Castillo M, Milla E (2014) Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma. Hematol Oncol Stem Cell Ther 7:149–156. https://doi.org/10.1016/j.hemonc.2014.09.001

Article  PubMed